Overview

Cardiac Arrhythmia Monitoring Devices Market is poised to value USD 10077 million by 2028 end at a CAGR of 6.7% during the forecast period 2022 to 2028.

For cardiac arrhythmias, numerous treatments have been developed. The commonest of these is the use of antiarrhythmic drugs, artificial pacemakers, implanted cardiac defibrillators, and ablation of damaged or malfunctioning cardiac tissue. An accurate diagnosis, however, is key to allowing a physician to determine the best treatment course for a patient. An electrocardiogram (ECG) can be obtained by a cardiac monitor and used by the physician to confirm or rule out arrhythmias. To maximize the outcome of a successful diagnosis, the physician should use the symptoms described by the patient to determine which method of cardiac monitoring is appropriate. A variety of devices can be used to remotely assess cardiac rhythm abnormalities in ambulatory patients. Patient- and event-activated intermittent recorders make up the largest segment of the market. In addition to these external or implanted devices, continuous-loop recorders can also be worn pre-symptomatically or post-symptomatically. The newest category of remote cardiac monitoring features four commercially available devices for continuous monitoring in real-time. The devices are capable of transmitting ECG data to a monitoring station that is being attended. There has been an increase in the rate of arrhythmias and their associated mortality in this context. Increasing mortality rates caused by arrhythmias have been a significant factor that has spurred the industry. With the increasing number of patients suffering from cardiovascular diseases, the market is expected to witness lucrative growth in the future. The market is also expected to grow with the progress of technological advancements and innovations.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cardiac Arrhythmia Monitoring Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cardiac Arrhythmia Monitoring Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Increasing research studies pertaining to the development of arrhythmia monitoring devices are estimated to drive the market over the forthcoming years. Technologies such as rhythm strip generating smartphone devices by Cardiac Designs (ECG Check) and AliveCor (Kardia Mobile) have resulted in the expansion of arrhythmia monitoring and wearable technology.

The mobile cardiac telemetry segment is anticipated to experience the fastest growth during the forecast period. These devices read cardiac rhythm with the help of external devices consisting of metal sensors. In addition, some of the monitoring functions offered by smartphones use photo-plethysmography through phone cameras to detect atrial fibrillation.

Major players included in the Cardiac Arrhythmia Monitoring Devices Market:
• NUUBO Smart Solutions Technologies, SL 
• Koninklijke Philips N.V.
• Welch Allyn – A Hill-Rom Inc. Company
• GE Healthcare
• Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
• Nihon Kohden Corporation
• Fukuda Denshi Co., Ltd.
• Biotelemetry, Inc.
• AliveCor, Inc.
• Biotronik, Inc.
• Medronic, Plc.
• St. Jude Medical, LLC. (Abbott Laboratories)
(Note: The list of the major players will be updated with the latest market scenario and trends)

Cardiac Arrhythmia Monitoring Devices Market Segmentation:
By Product Type
• Implantable Cardiac Monitors
• Resting ECG Devices
• ECG Stress Test Devices
• Mobile Cardiac Telemetry Monitors
• Holter Monitors
By End User
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Homecare Settings
• Long Term Care Centers
• Emergency Medical Services
By Application
• Atrial Fibrillation
• Bradycardia
• Conduction Disorders
• Premature Contraction
• Tachycardia
• Ventricular Fibrillation
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Cardiac Arrhythmia Monitoring Devices Market Sample Video:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Cardiac Arrhythmia Monitoring Devices Market By Product Type, By End User, By Application and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Cardiac Arrhythmia Monitoring Devices Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Cardiac Arrhythmia Monitoring Devices Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Cardiac Arrhythmia Monitoring Devices Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Cardiac Arrhythmia Monitoring Devices Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Implantable Cardiac Monitors
   7.2. Resting ECG Devices
   7.3. ECG Stress Test Devices
   7.4. Mobile Cardiac Telemetry Monitors
   7.5. Holter Monitors

8. Cardiac Arrhythmia Monitoring Devices Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Hospitals
   8.2. Ambulatory Surgical Centers
   8.3. Diagnostic Centers
   8.4. Homecare Settings
   8.5. Long Term Care Centers
   8.6. Emergency Medical Service

9. Cardiac Arrhythmia Monitoring Devices Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
   9.1. Atrial Fibrillation
   9.2. Bradycardia
   9.3. Conduction Disorders
   9.4. Premature Contraction
   9.5. Tachycardia
   9.6. Ventricular Fibrillation
   9.7. Others

10. North America Cardiac Arrhythmia Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Cardiac Arrhythmia Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Cardiac Arrhythmia Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Cardiac Arrhythmia Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. GCC
          14.2.2. Israel
          14.2.3. South Africa
          14.2.4. Rest of MEA
    14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    16.1. NUUBO Smart Solutions Technologies, SL 
          16.1.1. Company Overview
          16.1.2. Product Portfolio
          16.1.3. SWOT Analysis
          16.1.4. Financial Overview
          16.1.5. Strategic Overview
    16.2. Koninklijke Philips N.V.
          16.2.1. Company Overview
          16.2.2. Product Portfolio
          16.2.3. SWOT Analysis
          16.2.4. Financial Overview
          16.2.5. Strategic Overview 
    16.3. Welch Allyn – A Hill-Rom Inc. Company
          16.3.1. Company Overview
          16.3.2. Product Portfolio
          16.3.3. SWOT Analysis
          16.3.4. Financial Overview
          16.3.5. Strategic Overview
    16.4. GE Healthcare
          16.4.1. Company Overview
          16.4.2. Product Portfolio
          16.4.3. SWOT Analysis
          16.4.4. Financial Overview
          16.4.5. Strategic Overview
    16.5. Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
          16.5.1. Company Overview
          16.5.2. Product Portfolio
          16.5.3. SWOT Analysis
          16.5.4. Financial Overview
          16.5.5. Strategic Overview          
    16.6. Nihon Kohden Corporation
          16.6.1. Company Overview
          16.6.2. Product Portfolio
          16.6.3. SWOT Analysis
          16.6.4. Financial Overview
          16.6.5. Strategic Overview      
    16.7. Fukuda Denshi Co., Ltd.
          16.7.1. Company Overview
          16.7.2. Product Portfolio
          16.7.3. SWOT Analysis
          16.7.4. Financial Overview
          16.7.5. Strategic Overview
    16.8. Biotelemetry, Inc.
          16.8.1. Company Overview
          16.8.2. Product Portfolio
          16.8.3. SWOT Analysis
          16.8.4. Financial Overview
          16.8.5. Strategic Overview 
    16.9. AliveCor, Inc.
          16.9.1. Company Overview
          16.9.2. Product Portfolio
          16.9.3. SWOT Analysis
          16.9.4. Financial Overview
          16.9.5. Strategic Overview 
    16.10.Biotronik, Inc.
          16.10.1. Company Overview
          16.10.2. Product Portfolio
          16.10.3. SWOT Analysis
          16.10.4. Financial Overview
          16.10.5. Strategic Overview 
    16.11.Medronic, Plc.
          16.11.1. Company Overview
          16.11.2. Product Portfolio
          16.11.3. SWOT Analysis
          16.11.4. Financial Overview
          16.11.5. Strategic Overview      
    16.12.St. Jude Medical, LLC. (Abbott Laboratories)
          16.12.1. Company Overview
          16.12.2. Product Portfolio
          16.12.3. SWOT Analysis
          16.12.4. Financial Overview
          16.12.5. Strategic Overview 

17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the regulations initiated by healthcare administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures